Stein P L, Vogel H, Soriano P
Program in Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Genes Dev. 1994 Sep 1;8(17):1999-2007. doi: 10.1101/gad.8.17.1999.
Three members of the Src family of tyrosine kinases, src, fyn, and yes, are broadly expressed throughout mouse development. Mutations in the c-src and fyn genes were shown previously to lead to restricted nonoverlapping phenotypes only in a subset of cells in which these kinases are expressed. In this work we show that a mutation in the yes gene does not lead to an overt phenotype. Except for brain, the level or distribution of related kinases is not altered in major tissues. To gain further insight into the possibility that these kinases compensate for each other, animals deficient in multiple src-kinases were generated. Whereas most of the src/fyn or src/yes double mutants die perinatally, a substantial proportion of fyn/yes double mutants are viable but undergo degenerative renal changes leading to diffuse segmental glomerulosclerosis. Taken together, these data are consistent with the hypothesis that, at least in some cells, these kinases are able to compensate for the loss of the other related kinases.
酪氨酸激酶Src家族的三个成员,即Src、Fyn和Yes,在小鼠发育过程中广泛表达。先前已表明,c-Src和Fyn基因的突变仅在表达这些激酶的一部分细胞中导致有限的、不重叠的表型。在这项研究中,我们发现Yes基因的突变不会导致明显的表型。除大脑外,主要组织中相关激酶的水平或分布没有改变。为了进一步深入了解这些激酶相互补偿的可能性,我们构建了缺乏多种Src激酶的动物模型。大多数Src/Fyn或Src/Yes双突变体在出生时死亡,而相当一部分Fyn/Yes双突变体是存活的,但会发生退行性肾脏变化,导致弥漫性节段性肾小球硬化。综上所述,这些数据与以下假设一致:至少在某些细胞中,这些激酶能够补偿其他相关激酶的缺失。